Food and Drug Administration, Center for Drug Evaluation and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
Int J Pharm. 2010 Jan 29;385(1-2):92-7. doi: 10.1016/j.ijpharm.2009.10.040. Epub 2009 Oct 30.
The stability of metoprolol tartrate tablets packaged in original high density polyethylene containers and repackaged in USP Class A unit-dose blister packs was investigated. Studies were conducted at 25 degrees C/60% relative humidity (RH) for 52 weeks and at 40 degrees C/75% RH for 13 weeks. The potency, dissolution, water content, loss on drying and hardness of the drug products were analyzed. Results indicated no differences in the stability between the tablets in both packages stored under 25 degrees C/60% RH. No difference in potency was found in both packages under either condition. However, a significant weight increase due to moisture uptake was observed for the repackaged tablets stored under 40 degrees C/75% RH. The weight increase was accompanied by a decrease in tablet hardness (6.5-0 kp) and a increase in dissolution rate (51-92%) in 5 min. Near-infrared (NIR) chemical imaging also monitored moisture uptake of the tablet non-invasively through the package. The observed changes in product stability may adversely affect the products bioavailability profile, even though the potency of the active drug remained within USP specification range of 90-110%. Study results suggest product quality can be negatively impacted even when using USP Class A repackaging materials.
对原高密度聚乙烯容器包装的酒石酸美托洛尔片进行了研究,这些片剂被重新包装在 USP 一级单位剂量泡罩包装中。研究在 25°C/60%相对湿度(RH)下进行了 52 周,在 40°C/75%RH 下进行了 13 周。对药物产品的效力、溶解、水分含量、干燥失重和硬度进行了分析。结果表明,在 25°C/60%RH 下储存的两种包装中的片剂稳定性没有差异。在两种条件下,两种包装中的效力均无差异。然而,在 40°C/75%RH 下储存的重新包装片剂由于吸湿而导致重量显著增加。重量增加伴随着片剂硬度(6.5-0 kp)的降低和 5 分钟内溶解速率(51-92%)的增加。近红外(NIR)化学成像也通过包装非侵入性地监测了片剂的水分吸收。即使活性药物的效力仍在 USP 规定的 90-110%范围内,观察到的产品稳定性变化仍可能对产品的生物利用度产生不利影响。研究结果表明,即使使用 USP 一级包装材料,产品质量也可能受到负面影响。